glp_1 Glucagon-like peptide-1 caryophyllene) GLP-1 Medications – Community Education

The list includes medications with unique pharmacokinetic properties, such as: Clinically, these drugs are primarily prescribed for the treatment of type 2 diabetes, but they also have additional benefits in obesity management, cardiovascular risk reduction, and, to some extent, fatty liver disease

The effect of Semaglutide on mortality and COVID-19-related deaths: an analysis from the SELECT trial

The goal remains optimizing diabetes management or weight loss while maintaining acceptable tolerability and patient well-being

After discontinuing its internal GLP-1 in May of 2025 for causing liver issues, Pfizer won a bidding war against seven other companies for Metsera, which is developing a variety of incretin assets, paying $10 billion in one of 2025s largest M&A deals